Partnering

Compounding for growth

Press releases

| 05 July 2022

Fagron expands its US sterile compounding footprint with East coast acquisition

Fagron, the leading global player in pharmaceutical compounding, has acquired from Fresenius Kabi a 503B outsourcing facility in Boston.

Fagron

Our story

Together with prescribers and pharmacists, Fagron strives to improve personalized medicine and to make it (more) accessible for patients. In this way, we aim to have a significant impact on the health and welfare of people.

Partnering

Our process

A continuous focus on innovation, quality and efficiency is essential in consolidating our leading market positions. We start by exploring if our values are aligned for a potential partnership.

Our Process